GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GeNeuro SA (XPAR:GNRO) » Definitions » FFO

GeNeuro (XPAR:GNRO) FFO


View and export this data going back to 2016. Start your Free Trial

What is GeNeuro FFO?

FFO (Funds from operations) only applies to REITs.


GeNeuro Business Description

Traded in Other Exchanges
Address
3 chemin du Pre-Fleur, Plan-les-Ouates, Geneva, CHE, 1228
GeNeuro SA is a clinical-stage biopharmaceutical company focused on understanding and stopping causal factors driving the progression of neurodegenerative and autoimmune diseases. The company's therapeutic candidate, temelimab, is a humanized monoclonal antibody that neutralizes a pathogenic protein of the HERV-W family (W-ENV).